ECVTF Stock UPDATES Economic Inv TR Ord (ECVTF) 84.6420 08/05/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Economic Inv TR Ord (ECVTF) 84.6420 $ECVTF

Canadian & Foreign Securities Co. Limited Announces Acquisition of Common Shares of Economic Investment Trust Limited
Marketwire - Fri May 30, 12:09PM CDT
Canadian & Foreign Securities Co. Limited ("C&F" announces that it acquired a further 400 Common Shares of Economic Investment Trust Limited ("Economic" , increasing its ownership from 647,713 (11.534%) of the Common Shares to 648,113 (11.541%) of the Common Shares. C&F has an informal understanding with other shareholders of Economic under which they act in concert with respect to the voting of securities of Economic held by them. The purchase increases the ownership of C&F and these other shareholders from 4,600,029 (81.916%) of the Common Shares to 4,600,429 (81.923%) of the Common Shares. The purchase was effected through the facilities of the Toronto Stock Exchange for consideration of $90.00 per share. The purchase, and C&F's holding of Common Shares of Economic, are for investment purposes only. C&F may purchase further Common Shares from time to time, if in its judgment the shares represent a good investment in view of their price. C&F is relying on the exemption from the formal bid requirements set forth in section 100 of the Securities Act (Ontario). The normal course purchase exemption is available as C&F's purchase of 400 Common Shares (together with other purchases by C&F, and the other shareholders with which C&F acts in concert, in the preceding 12 months) did not exceed 5% of the outstanding Common Shares of Economic; there is an established market for the Common Shares; and, the value of the consideration paid for the Common Shares will not exceed the market price, plus reasonable brokerage fees or commissions actually paid.

2014 Strategies for the US Tumor Marker Testing Market
M2 - Thu Feb 13, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/jw5l9d/2014_strategies) has announced the addition of the "2014 Strategies for the US Tumor Marker Testing Market" report to their offering. Comprehensive 620-page analysis of the US tumor marker testing market. - Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. - Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. - Five-year test volume and sales forecasts over for 40 tumor marker performed in US hospitals, commercial laboratories and physician offices. - Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. - Current instrumentation technologies and feature comparison of leading analyzers. - Sales and market shares of leading suppliers. - Emerging diagnostic technologies and their potential market applications. - Product development opportunities. - Profiles of current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. - Business opportunities and strategic recommendations for suppliers. For more information visit http://www.researchandmarkets.com/research/jw...strategies

Brazil Orthopedic Devices Market Outlook to 2020
M2 - Thu Feb 13, 10:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/hsrm8x/brazil_orthopedic) has announced the addition of the "Brazil Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others" report to their offering. "Brazil Orthopedic Devices Market Outlook to 2020 - Arthroscopy, Cranio Maxillofacial Fixation (CMF), Hip Reconstruction, Knee Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others", provides key market data on the Brazil Orthopedic Devices market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Hip Reconstruction, Knee Reconstruction, Shoulder Reconstruction, Small Joint Reconstruction, Orthobiologics, Orthopedic Braces and Supports, Arthroscopy, Cranio Maxillofacial Fixation (CMF), Orthopedic Bone Cement and Casting Materials, Spinal Surgery, Trauma Fixation, Orthopedic Tools and Orthopedic Prosthetics. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Orthopedic Devices Market, Brazil 4 Arthroscopy Market, Brazil 5 Cranio Maxillofacial Fixation (CMF) Market, Brazil 6 Hip Reconstruction Market, Brazil 7 Knee Reconstruction Market, Brazil 8 Orthobiologics Market, Brazil 9 Orthopedic Bone Cement and Casting Materials Market, Brazil 10 Orthopedic Braces and Supports Market, Brazil 11 Orthopedic Prosthetics Market, Brazil 12 Orthopedic Tools Market, Brazil 13 Other Joint Reconstruction Market, Brazil 14 Spinal Surgery Market, Brazil 15 Trauma Fixation Market, Brazil 16 Overview of Key Companies in Brazil Orthopedic Devices Market 17 Orthopedic Devices Market Pipeline Products 18 Financial Deals Landscape 19 Recent Developments 20 Appendix Companies Mentioned - DePuy Companies - Smith & Nephew Plc - Stryker Corporation - Zimmer Holdings, Inc. - Arthrex, Inc. - Medtronic, Inc. - Biomet, Inc. - B. Braun Melsungen AG - 3M Health Care Ltd. - Wright Medical Group, Inc. - ConMed Corporation - BSN medical GmbH - Corin Group PLC - Tornier N.V. For more information visit http://www.researchandmarkets.com/research/hs...orthopedic

IIROC Trade Resumption - EVT
CNW Group - Wed Feb 12, 1:16PM CST
Trading resumes in:

IIROC Trading Halt - EVT
CNW Group - Wed Feb 12, 12:43PM CST
The following issues have been halted by IIROC:

IIROC Trade Resumption - Economic Investment Trust Limited
Newsfile Corp - Wed Feb 12, 12:40PM CST
Trading resumes in:

IIROC Trade Halt - Economic Investment Trust Limited
Newsfile Corp - Wed Feb 12, 12:39PM CST
The following issues have been halted by IIROC:

Economic Investment Trust Limited Announces Dividend
Marketwire - Wed Feb 12, 12:33PM CST
The Board of Directors of Economic Investment Trust Limited (TSX: EVT) today declared a cash dividend of $7.20 per Common Share payable March 31, 2014 to shareholders of record on March 14, 2014.

Economic Investment Trust Limited Announces Outcome of Director Elections
Marketwire - Wed Apr 10, 12:45PM CDT
Economic Investment Trust Limited (TSX: EVT) reports the following voting results for the election of directors at its Annual Meeting of Shareholders held on April 2, 2013:



Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 183

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 742

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 235

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 63

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 437

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 209

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 256

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 222

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 490

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 221

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading

Top 5 Most Recently Viewed Articles

Marina Genova Joins SEA Index to Promote Sustainable Yachting

Updated Category News Views 173

Marina Genova Enters SEA Index as an Institutional Member Recently, the Superyacht Eco Association – SEA Index welcomed Marina Genova, a prominent destination for yachting in the Mediterranean, as an Institutional Member. This collaboration signifies a crucial step in the yachting community's commitment to integrating environmental sustainability into its operations....

Continue Reading
Warren Buffett’s Top 2025 Stock Picks You Need to Know

Updated Category News Views 2610

Warren Buffett’s Strategic Stock Investments for 2025 Warren Buffett, the Oracle of Omaha, is known for his keen investment strategies and ability to recognize value in both good and bad market conditions. In the current volatile landscape, his portfolio continues to evolve, with some old favorites and new bets that show his forward-thinking approach. As we look ahead...

Continue Reading
Graves' Ophthalmopathy Market Surges with New Therapies

Updated Category News Views 50

Unexpected Growth in Graves' Ophthalmopathy Market Over the next decade, we're seeing the Graves' ophthalmopathy market gearing up for some serious growth, clocking in at a hefty compound annual growth rate of 9%. A good chunk of this is thanks to Viridian's newest player, LUMVOA, getting the green light, sending competitors scrambling and pushing innovation into...

Continue Reading
Tris Pharma Launches ONYDA XR: A New ADHD Liquid Solution

Updated Category News Views 210

So back in 2024, Tris Pharma rolled out ONYDA™ XR—this liquid medication aimed at tackling ADHD in kids six and older. It was billed as a game changer, especially since the FDA gave it the green light. The desks were buzzing about this first-of-its-kind non-stimulant therapy, positioning it like a golden ticket for parents tired of conventional stimulants that might...

Continue Reading
JPMorgan Updates Price Target for W. P. Carey to $70

Updated Category News Views 242

JPMorgan Boosts W. P. Carey's Price Target Recently, JPMorgan has refreshed its price target for W. P. Carey & Co. (NYSE: WPC), raising it from $68.00 to $70.00, while retaining an Overweight rating on the stock. This adjustment comes ahead of the company’s third-quarter earnings announcement, indicating the firm's confidence in W. P. Carey’s future potential....

Continue Reading